<DOC>
	<DOCNO>NCT00898391</DOCNO>
	<brief_summary>This research trial study deoxyribonucleic acid ( DNA ) blood sample patient neuroblastoma . Studying sample blood patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment .</brief_summary>
	<brief_title>Study DNA Blood Samples From Patients With Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : I . Perform blind study multicentric study analyze serum patient diagnosis ( know tumor v-myc avian myelocytomatosis viral oncogene neuroblastoma derive homolog ( MYCN ) status determine Children 's Oncology Group [ COG ] reference lab ) , order confirm previous data define appropriate MYCN/control ratio cutoff capable determine positive negative case . II . Define limit procedure non-metastatic patient reduced tumor burden ( International Neuroblastoma Staging System [ INSS ] stage 1 2 ) . OUTLINE : Circulating DNA extract serum . Polymerase chain reaction ( PCR ) amplification MYCN perform analyze agarose gel electrophoresis . Real-time quantitative PCR also perform .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>Serum sample neuroblastoma ( NB ) patient obtain COG ( legacy Children 's Cancer Group [ CCG ] /Pediatric Oncology Group [ POG ] Biology Studies ) The MYCN status correspond tumor determine use standard technique ; panel sample must obtain NB patient without MYCN amplification tumor Cases draw clinical subset great likelihood benefit test ability , stage 1 2 NBs ( infant toddler ) , stage 4 patient 18 month age , 4S patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>